Tuberous sclerosis complex (TSK) shows autosomal dominant inheritance and it is a disease seen as a result of mutation of genes known as TSC1 and TSC2. It affects many systems and mostly affects kidney, brain, heart, liver, retina and skin. Almost all of the patients have typical skin manifestations of one or more diseases and in most patients epilepsy is very common. Epilepsy can be the best symptom of TSK. The incidence of TSK is approximately 1 / 5000-10000. In this article the incidence of LAM with pulmonary involvement of tuberous sclerosis is 1 / 1.000.000. LAM is a cystic lung disease that may lead to limitations in pulmonary functions. The most common features are dyspnea and pneumothorax and it’s more common in women than men. Cystic destruction of the lung and smooth muscle cell infiltration is a disease. Pulmonary parenchyma as pathological finding, located in the thorax and abdomen is characterized by smooth muscle cell proliferation in lymphatics. LAM diagnosis is typically diagnosed with high resolution computerized tomography (HRCT) with who has exercize dispnea and in patients with recurrent pneumothorax or less as when doubted lymphoma and abdominal tumor is diagnosed after biopsy or operations. In cases where radiological examinations are not characteristic for LAM for definitive diagnosis, lung biopsy should be performed.
Birincil Dil | Türkçe |
---|---|
Konular | Sağlık Kurumları Yönetimi |
Bölüm | Araştırma Makaleleri |
Yazarlar | |
Yayımlanma Tarihi | 1 Temmuz 2019 |
Yayımlandığı Sayı | Yıl 2019 Cilt: 1 Sayı: 2 |